Hepatitis B Virus (HBV)

CAS No.	Product Name	Inquiry
2388520-33-8	TLR7/8 agonist 4 TLR7/8 agonist 4 is a potent TLR7/8 agonist with anti-cancer activity.
2413192-48-8	cis-ccc_R08
2413192-49-9	trans-ccc_R08
2413192-50-2	HBV-IN-15 HBV-IN-15 is a potent inhibitor of covalently closed circular DNA (cccDNA). cccDNA serves as the template for viral RNA transcription and subsequent viral DNA generation. HBV-IN-15 is a flavone derivative. HBV-IN-16 has the potential for the research of HBV infection.
2413192-59-1	Hbv-IN-29
2413192-92-2	Hbv-IN-30
2413192-95-5	Hbv-IN-31
2413193-04-9	Hbv-IN-32
2413649-89-3	HBV-IN-23 HBV-IN-23 (Compound 5k) is an inhibitor of HBV DNA replication with an IC50 of 0.58 µM. HBV-IN-23 inhibits HBV DNA replication in both drug sensitive and resistant HBV strains. HBV-IN-23 shows anti-hepatocellular carcinoma cell (HCC) activities. HBV-IN-23 induces HepG2 cells Apoptosis.
2415-24-9	Catalpol Catalpol is a natural iridoid found in the herb of Rehmannia glutinosa (Gaert.) Libosch. ex Fisch. et Mey. It is a kind of enzyme inhibitor with antihistaminic activity. Catalpol also exhibits the activity of anti-inflammatory.
2445597-31-7	AB-836
2450-53-5	Isochlorogenic acid A 3,5-Di-O-caffeoylquinic acid isolated from the flowerbud of Lonicera japonica Thunb. It has hepatoprotective and potent anti-hepatitis B activities.
2457357-99-0	FNC-TP FNC-TP is the intracellular active form of FNC which is a potent nucleoside reverse transcriptase inhibitor (NRTI), with antiviral activity on HIV, HBV and HCV.
2460957-52-0	HBV-IN-21 HBV-IN-21 (Compound II-8b) is an HBV DNA replication inhibitor with an IC50 of 2.2 µM. HBV-IN-21 can interact HBV 4 capsid protein with good affinity (KD = 60.0 μM).
2469195-67-1	Bifendate-d6 Bifendate-d6 (DDB-d6) is the deuterium labeled Bifendate. Bifendate (DDB) is a synthetic intermediate of Schisandrin C with anti-HBV efficacy in research of chronic hepatitis B.
25334-23-0	Nicotinamide Hydrochloride
2538784-48-2	Xalnesiran Xalnesiran, a revolutionary RNA-targeted pharmaceutical compound, has emerged as a cutting-edge treatment option for a spectrum of liver ailments such as non-alcoholic steatohepatitis (NASH) and hepatocellular carcinoma (HCC). Through precise mechanisms of action that involve suppression of critical disease-related genes, it showcases unparalleled efficacy in halting disease progression.
2538784-49-3	Xalnesiran sodium Xalnesiran (sodium) is siRNA for the treatment of chronic hepatitis B ( HBV ).
2563929-84-8	Bepirovirsen sodium
2569526-80-1	Yhhu6669

※ Please kindly note that our services are for research use only.